These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 24557088)

  • 1. Dutasteride reduces alcohol's sedative effects in men in a human laboratory setting and reduces drinking in the natural environment.
    Covault J; Pond T; Feinn R; Arias AJ; Oncken C; Kranzler HR
    Psychopharmacology (Berl); 2014 Sep; 231(17):3609-18. PubMed ID: 24557088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variation in AKR1C3, which encodes the neuroactive steroid synthetic enzyme 3α-HSD type 2 (17β-HSD type 5), moderates the subjective effects of alcohol.
    Milivojevic V; Feinn R; Kranzler HR; Covault J
    Psychopharmacology (Berl); 2014 Sep; 231(17):3597-608. PubMed ID: 24838369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GABRA2 alleles moderate the subjective effects of alcohol, which are attenuated by finasteride.
    Pierucci-Lagha A; Covault J; Feinn R; Nellissery M; Hernandez-Avila C; Oncken C; Morrow AL; Kranzler HR
    Neuropsychopharmacology; 2005 Jun; 30(6):1193-203. PubMed ID: 15702134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized Placebo-Controlled Clinical Trial of Dutasteride for Reducing Heavy Drinking in Men.
    Covault J; Tennen H; Feinn R
    J Clin Psychopharmacol; 2024 May-Jun 01; 44(3):223-231. PubMed ID: 38684046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GRIK1 and GABRA2 Variants Have Distinct Effects on the Dose-Related Subjective Response to Intravenous Alcohol in Healthy Social Drinkers.
    Yang BZ; Arias AJ; Feinn R; Krystal JH; Gelernter J; Petrakis IL
    Alcohol Clin Exp Res; 2017 Dec; 41(12):2025-2032. PubMed ID: 29131352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adaptation of Subjective Responses to Alcohol is Affected by an Interaction of GABRA2 Genotype and Recent Drinking.
    Kosobud AE; Wetherill L; Plawecki MH; Kareken DA; Liang T; Nurnberger JL; Windisch K; Xuei X; Edenberg HJ; Foroud TM; O'Connor SJ
    Alcohol Clin Exp Res; 2015 Jul; 39(7):1148-57. PubMed ID: 26087834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A GABRA2 variant is associated with increased stimulation and 'high' following alcohol administration.
    Arias AJ; Covault J; Feinn R; Pond T; Yang BZ; Ge W; Oncken C; Kranzler HR
    Alcohol Alcohol; 2014; 49(1):1-9. PubMed ID: 24166645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alcohol intake increases high-grade prostate cancer risk among men taking dutasteride in the REDUCE trial.
    Fowke JH; Howard L; Andriole GL; Freedland SJ
    Eur Urol; 2014 Dec; 66(6):1133-8. PubMed ID: 24568894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dutasteride in men receiving testosterone therapy: a randomised, double-blind study.
    Kacker R; Harisaran V; Given L; Miner M; Rittmaster R; Morgentaler A
    Andrologia; 2015 Mar; 47(2):148-52. PubMed ID: 24499051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alcohol-Induced Stimulation Mediates the Effect of a GABRA2 SNP on Alcohol Self-Administrated among Alcohol-Dependent Individuals.
    Boyd SJ; Schacht JP; Prisciandaro JJ; Voronin K; Anton RF
    Alcohol Alcohol; 2016 Sep; 51(5):549-54. PubMed ID: 27117237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the brief Biphasic Alcohol Effects Scale (B-BAES).
    Rueger SY; King AC
    Alcohol Clin Exp Res; 2013 Mar; 37(3):470-6. PubMed ID: 23078583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alcohol subjective responses in heavy drinkers: Measuring acute effects in the natural environment versus the controlled laboratory setting.
    Fridberg DJ; Cao D; King AC
    Alcohol Clin Exp Res; 2021 Jun; 45(6):1287-1297. PubMed ID: 33864396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of dutasteride on prostate cancer risk reduction in Asian men: the results from the REDUCE study.
    Akaza H; Kanetake H; Tsukamoto T; Miyanaga N; Sakai H; Masumori N; Nakatsu H; Sagiyama K; Sakamoto S; Endo Y; Yamanouchi T;
    Jpn J Clin Oncol; 2011 Mar; 41(3):417-23. PubMed ID: 21123311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dutasteride reduces prostate size and prostate specific antigen in older hypogonadal men with benign prostatic hyperplasia undergoing testosterone replacement therapy.
    Page ST; Hirano L; Gilchriest J; Dighe M; Amory JK; Marck BT; Matsumoto AM
    J Urol; 2011 Jul; 186(1):191-7. PubMed ID: 21575967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of ethanol on serum GABAergic 3alpha,5alpha/3alpha,5beta neuroactive steroids in mice, rats, cynomolgus monkeys, and humans.
    Porcu P; O'Buckley TK; Alward SE; Song SC; Grant KA; de Wit H; Leslie Morrow A
    Alcohol Clin Exp Res; 2010 Mar; 34(3):432-42. PubMed ID: 20028362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dutasteride reduces prostatitis symptoms compared with placebo in men enrolled in the REDUCE study.
    Nickel JC; Roehrborn C; Montorsi F; Wilson TH; Rittmaster RS
    J Urol; 2011 Oct; 186(4):1313-8. PubMed ID: 21849186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomised, double-blind study comparing the addition of bicalutamide with or without dutasteride to GnRH analogue therapy in men with non-metastatic castrate-resistant prostate cancer.
    Chu FM; Sartor O; Gomella L; Rudo T; Somerville MC; Hereghty B; Manyak MJ
    Eur J Cancer; 2015 Aug; 51(12):1555-69. PubMed ID: 26048455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity is associated with increased prostate growth and attenuated prostate volume reduction by dutasteride.
    Muller RL; Gerber L; Moreira DM; Andriole G; Hamilton RJ; Fleshner N; Parsons JK; Freedland SJ
    Eur Urol; 2013 Jun; 63(6):1115-21. PubMed ID: 23541458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of testosterone supplementation with and without a dual 5α-reductase inhibitor on fat-free mass in men with suppressed testosterone production: a randomized controlled trial.
    Bhasin S; Travison TG; Storer TW; Lakshman K; Kaushik M; Mazer NA; Ngyuen AH; Davda MN; Jara H; Aakil A; Anderson S; Knapp PE; Hanka S; Mohammed N; Daou P; Miciek R; Ulloor J; Zhang A; Brooks B; Orwoll K; Hede-Brierley L; Eder R; Elmi A; Bhasin G; Collins L; Singh R; Basaria S
    JAMA; 2012 Mar; 307(9):931-9. PubMed ID: 22396515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial.
    Fleshner NE; Lucia MS; Egerdie B; Aaron L; Eure G; Nandy I; Black L; Rittmaster RS
    Lancet; 2012 Mar; 379(9821):1103-11. PubMed ID: 22277570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.